Complex treatment regimens; a growing number of combination therapies; new indications and approvals; and continually changing authorization and reimbursement requirements can make treatment with oral oncolytics challenging for both patients and providers.
The cost of these therapies can pose an additional barrier for patients who are good candidates for these drugs. Oncology pharmacists can help address these issues by taking on an expanded role, educating providers and patients about these therapies and collaborating with nurse navigators and financial advocates to ease patient access to treatments. New solutions to promote the use of oral oncolytics—including a range of digital and decision-support tools that can enhance compliance monitoring and reporting—can help oncology pharmacists support patient adherence to treatment. Opening an in-house dispensing pharmacy may help smooth the adoption of oral oncolytics by avoiding potential delays with specialty pharmacies and enabling patients to obtain their medications and regimen-specific education during office visits.